Treatment challenges fuel the silent hepatitis C epidemic

Multiple Sclerosis: ‘You don’t die from MS, you die with it’
June 13, 2017
Tip Sheet: Immunotherapy Trial Results for Cancer Among Research Presentations by Johns Hopkins Scientists
June 13, 2017
Show all

Treatment challenges fuel the silent hepatitis C epidemic

The challenges of getting hepatitis C treatment to those who need it.

The United States has reached a critical point in the hepatitis C epidemic: the virus affects at least 3.5 million Americans. Chronic hepatitis C infection is now the leading cause of liver cancer and it causes more deaths than any other blood-borne infectious disease. Untreated, the virus can destroy the liver’s ability to filter blood and produce proteins that protect our bodies from infection.

Many people don’t even realize they have hepatitis C, as the infection can go for decades without causing any symptoms. People who are infected can transmit infection to others through exposure to their blood. The primary treatment for hepatitis C infection, until very recently, was interferon therapy, which requires months of treatment and is brutally toxic, and not always effective.

Read full article: Treatment challenges fuel the silent hepatitis C epidemic | TheHill

Read Full Article: Treatment challenges fuel the silent hepatitis C epidemic | TheHill

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.